Sorrento Therapeutics Inc. (SRNE): $7.20

-0.31 (-4.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SRNE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 491

in industry

Sorrento Therapeutics Inc (SRNE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Sorrento Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $35 $21 $28 $7.58 269.39%

The Trend in the Analyst Price Target


Over the past 84 days, SRNE's average price target has gone up $2.5.

Over the past 297 days, SRNE's average upside potential has been 201.12%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-06-10 2 24 24 24.00 4.540 428.63%
2020-07-30 2 30 24 27.00 8.550 215.79%
2020-08-25 2 30 21 25.50 8.225 210.03%
2020-10-13 2 30 21 25.50 11.950 113.39%
2020-11-08 1 21 21 21.00 6.980 200.86%
2020-11-28 2 30 21 25.50 8.150 212.88%
2020-12-07 2 30 21 25.50 7.690 231.6%
2020-12-09 2 30 21 25.50 8.210 210.6%
2020-12-19 2 30 21 25.50 7.350 246.94%
2020-12-26 2 30 21 25.50 7.890 223.19%
2021-01-02 2 30 21 25.50 6.825 273.63%
2021-01-09 2 30 21 25.50 7.440 242.74%
2021-01-16 2 30 21 25.50 9.500 168.42%
2021-01-23 3 35 21 28.67 9.640 197.41%
2021-01-30 4 35 21 28.00 12.660 121.17%
2021-02-06 4 35 21 28.00 13.960 100.57%
2021-02-13 4 35 21 28.00 14.390 94.58%
2021-02-20 4 35 21 28.00 13.150 112.93%
2021-02-27 4 35 21 28.00 9.670 189.56%
2021-03-06 4 35 21 28.00 8.880 215.32%
2021-03-13 4 35 21 28.00 10.250 173.17%
2021-03-20 4 35 21 28.00 9.560 192.89%
2021-04-03 4 35 21 28.00 8.010 249.56%

SRNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 0 4 0 0 0 4

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SRNE has a greater upside potential (average analyst target price relative to current price) than 95.62% of all US stocks.
  • The number of analysts covering the stock of SRNE is higher than 20.15% of stocks in the mid market cap category.
  • The variance in analysts' estimates of SRNE is lower than 25.19% of all US stocks.
  • SRNE has a higher average analyst price target than 35.6% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, CNSP, CBIO and MNOV are the three stocks most similar to Sorrento Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is SRNE a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0032 seconds.